New Report Benchmarks Critical Biopharmaceutical Quality & CAPA Processes
CHAPEL HILL, N.C., July 24, 2015 /PRNewswire/ -- A well-defined CAPA system is essential for any biopharmaceutical company to drive quality improvements across the organization. Hence, it is imperative for biopharmaceutical organizations to measure the effectiveness of their CAPA processes to identify potential areas of improvement in their quality function.
According to recent research by Best Practices, LLC, companies are still trying to find the best ways to measure the effectiveness of their CAPA processes. This can be extremely challenging, as there is no "one size fits all" approach, due to the difference in products and processes amongst companies. Currently more than half of benchmark participants use number of recurrences and number of repeats to measure the effectiveness of CAPA processes.
The related report, "Benchmarking BioPharma Quality and CAPA Processes," provides leaders with critical benchmarks on CAPA processes and quality resource management. Pharma & Medical Device executives can utilize this study to build a strong CAPA system and thereby develop a robust quality function, within tight budgets.
Key research objectives included:
- Assessing CAPA Processes
- Uncovering Benchmarks For CAPAs, NCEs, FDA Questions, Inspections And Observations
- Defining CAPA Effectiveness Metrics
- Measuring The True Cost Of Quality
- Highlighting Strategies To Manage Quality Costs And Align Spend Mix
This benchmarking research drew participation from 14 executives from leading biopharmaceutical organizations. Data is charted throughout the report for the "Total Benchmark Class" as well as for the "Large Company Segment", which includes 9 companies.
To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1367.htm
For more information on other recent primary research studies, contact us at 919.403.0251. For related research, visit our Best Practices, LLC website at http://www.best-in-class.com/
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.